The chemistry of drugs /

QR Code

The chemistry of drugs /

Saved in:

Bibliographic Details
Main Author:	Evers, Norman
Other Authors:	Caldwell, Dennis
Format:	Book
Language:	English
Published:	London : E. Benn, 1959.
Edition:	3rd ed., entirely revised and enlarged.
Subjects:	Drugs > therapeutic equivalency. Drugs > analysis.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE?
by: V. V. Iakusevich
Published: (2016-01-01)

SOME ASPECTS OF EFFECTIVENESS AND SAFETY OF ANTIBACTERIAL DRUGS IN PREGNANCY
by: D. Y. Zhukova, et al.
Published: (2012-05-01)

The analysis of drugs and chemicals /
by: Evers, Norman
Published: (1955)

Original drugs and generics: are there any differences from the clinician’s point of view?
by: S. Yu. Martsevich, et al.
Published: (2024-10-01)

Interchangeability of glibenclamide-containing drugs
by: G. I. Gorodetskaya, et al.
Published: (2018-02-01)

Determination of Serum/Plasma Concentrations of Psychotropic Drugs in Therapeutic Drug Monitoring
by: I. I. Miroshnichenko, et al.
Published: (2021-09-01)

PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Development of Drug-Device Combination Products and Generic Substitution in the United States
by: YoonJung Lee, et al.
Published: (2025-07-01)

Peculiarities of approaches to assessing the interchangeability of antiepileptic drugs
by: E. O. Zhuravleva, et al.
Published: (2018-02-01)

Assessment of the Feasibility of Therapeutic Equivalence Studies
by: D. V. Goryachev, et al.
Published: (2019-06-01)

A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Interchangeability of Fluconazole Drugs
by: N. D. Bunyatyan, et al.
Published: (2018-12-01)

ECONOMIC REASONS FOR GENERIC CHOICE
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

THE ROLE OF THE THERAPEUTIC DRUG MONITORING WHEN USING ANTIEPILEPTIC DRUGS
by: A. V. Yakunina, et al.
Published: (2016-12-01)

VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

“Adequate dose” in the drug treatment of mental disorders
by: V. L. Kozlovskii, et al.
Published: (2023-07-01)

TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01)

Therapeutic Drug Monitoring of Antibiotics Is Needed in the Treatment of Sepsis
by: G. P. Plotnikov, et al.
Published: (2022-12-01)

Safety of Use of Russian Biosimilars of Interferon Beta-1b in the Treatment of Multiple Sclerosis: a Meta-analysis of Original Studies
by: D. O. Gudz, et al.
Published: (2019-06-01)

EFFICACY AND SAFETY OF ANTIEPILEPTIC DRUGS DURING PREGNANCY: PHARMACOGENETIC ASPECTS
by: E. A. Sоkоvа, et al.
Published: (2018-06-01)

RESULTS OF THERAPEUTIC DRUG MONITORING COMBINATION THERAPY OF ANTICONVULSANTS IN CLINICAL PRACTICS
by: M. V. Leonova, et al.
Published: (2016-05-01)

Liposomes for drug delivery: Classification, therapeutic applications, and limitations
by: Ramachandran Chelliah, et al.
Published: (2025-01-01)

Determination of the Effectiveness of Antibiotic Therapy by Conducting Therapeutic Drug Monitoring
by: A. M. Kazanova, et al.
Published: (2020-06-01)

A Call to Action: Empowering Pharmacists in Drug-Resistant Tuberculosis Management
by: Alfaqeeh M, et al.
Published: (2025-06-01)

Guideline for the use of therapeutic drug monitoring of antipsychotics to individualize the selection of therapy in the treatment of exacerbation of schizophrenia
by: S. S. Potanin, et al.
Published: (2023-12-01)

Unexpected falsely high vancomycin concentrations in a patient with endocarditis during routine therapeutic drug monitoring
by: Laura Galán-Caballero, et al.
Published: (2025-06-01)

THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CLINICAL PRACTICS
by: Yu. B. Belousov, et al.
Published: (2016-05-01)

Therapeutic drug monitoring of methotrexate and its metabolites in the red blood cells and mononuclear cells of patients with rheumatoid arthritis
by: G. I. Gridneva, et al.
Published: (2020-11-01)

THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CHILDREN IN CLINICAL PRACTICE
by: M. V. Leonova, et al.
Published: (2017-05-01)

Recent Trends in Tailored Treatments for Helicobacter pylori Infection
by: Hyungchul Park, et al.
Published: (2021-06-01)

RETROSPECTIVE OF DISSOLUTION TEST OF SOLID DOSAGE FORMS (REVIEW)
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01)

MODERN APPROACHES OF DISSOLUTION PROFILE TEST (REVIEW)
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01)

Pharmacotherapy in a Multidisciplinary Paediatric Hospital: Polypharmacy and Drug–Drug Interaction Risk Illustrated with a Clinical Case
by: M. N. Kostyleva, et al.
Published: (2022-10-01)

ДЖЕНЕРИЧЕСКИЕ СТАТИНЫ В КЛИНИЧЕСКОЙ ПРАКТИКЕ: ДЕШЕВЫЕ ЗАМЕНИТЕЛИ ИЛИ ДОСТОЙНАЯ АЛЬТЕРНАТИВА БРЕНДАМ. АТОРВАСТАТИН
by: В. П. Михин, et al.
Published: (2012-04-01)

Pharmacokinetic analysis of meropenem therapeutic drug monitoring data (TDM) in critically ill adult patients
by: I. B. Bondareva, et al.
Published: (2022-03-01)

Therapeutic Drug Monitoring for Evaluation of the Efficacy and Safety of Vancomycin in Patients with Orthopaedic Infections
by: O. S. Tufanova, et al.
Published: (2022-07-01)

Clinical and Pharmacological Approaches to the Prescription of Centrally Acting Antihypertensive Drugs for Uncontrolled Arterial Hypertension
by: A. V. Strygin, et al.
Published: (2020-11-01)

Multi-omics dissection of tumor microenvironment-mediated drug resistance: mechanisms and therapeutic reprogramming
by: Fanghua Chen, et al.
Published: (2025-07-01)

Features of drug-drug interactions rivaroxaban and calcium channel blockers depending on the ABCB1 genotype (rs1045642 and rs4148738) in patients 80 years of age and older with non-valvular atrial fibrillation
by: D. A. Sychev, et al.
Published: (2024-01-01)